Patents matching “626”

US 8476263

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Jul 2, 2013 · Expires Jun 27, 2033

US 8466267

Nucleic acid encoding a zinc finger that recognizes the sodium channel Nav 1.8 (PN3) gene

Sangamo Biosciences, Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

US 8431626

Disulfide monomers comprising ethylenically unsaturated norbornyl groups suitable for dental compositions

The Regents of the University of Colorado · Granted Apr 30, 2013 · Expires Apr 25, 2033

US 8168626

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 1, 2012 · Expires Apr 26, 2032

US 8105626

Granules containing acid-unstable chemical in large amount

Takeda Pharmaceutical Company Limited · Granted Jan 31, 2012 · Expires Jan 26, 2032

US 8062640

High affinity human antibodies to PCSK9

REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2011 · Expires Nov 17, 2031

US 8062647

High concentration baclofen preparations

The Board of Regents of the University of Texas System · Granted Nov 22, 2011 · Expires Nov 17, 2031

US 8062643

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Nov 22, 2011 · Expires Nov 17, 2031

US 8062654

Drug releasing biodegradable fiber for delivery of therapeutics

The Board of Regents of the University of Texas System · Granted Nov 22, 2011 · Expires Nov 17, 2031

US 8026263

Methods for inhibiting neoproliferative changes in blood vessel walls

The Regents of the University of California · Granted Sep 27, 2011 · Expires Sep 22, 2031

US 7943626

Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

US 7862605

Coated implantable medical device

Cook Regentec LLC · Granted Jan 4, 2011 · Expires Dec 30, 2030

US 2010247626

PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION

ALBRECHT VOLKER [DE] · Granted Sep 30, 2010 · Expires Sep 25, 2030

US 7732626

Fused cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Jun 8, 2010 · Expires Jun 3, 2030

US 7662607

Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

New Century Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

US 7662619

Sol-fusin: use of GP64-6His to catalyze membrane fusion

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

US 7626014

Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2009 · Expires Nov 26, 2029

US 7626042

O-substituted hydroxyaryl derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Dec 1, 2009 · Expires Nov 26, 2029

US 7462635

Thiazole and oxazole VDAC regulator

Takeda Pharmaceutical Company Limited · Granted Dec 9, 2008 · Expires Dec 4, 2028

US 7462603

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

The Regents of the University of California · Granted Dec 9, 2008 · Expires Dec 4, 2028

US 7462628

Preventives/remedies for urinary disturbance

Takeda Pharmaceutical Company Limited · Granted Dec 9, 2008 · Expires Dec 4, 2028

US 7462625

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Dec 9, 2008 · Expires Dec 4, 2028

US 7462612

Pyridine inhibitors of ERK2 and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Dec 9, 2008 · Expires Dec 4, 2028

US 7462691

Mouse prostate stem cell antigen and uses thereof

The Regents of the University of California · Granted Dec 9, 2008 · Expires Dec 4, 2028